Belite Bio (BLTE) Times Interest Earned (2024 - 2025)
Belite Bio (BLTE) posted quarterly Times Interest Earned of $2.48 for Q1 2026, up 100.0% year-over-year from $1.24 in Q1 2025, and up 103443.81% quarter-over-quarter from -$0.0 in Q4 2025.
Analysis
Belite Bio (BLTE) Times Interest Earned (2024 - 2025) Analysis & Trends
Belite Bio's Times Interest Earned history runs 5 years deep, the most recent figure standing at $2.48 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 100.0% year-over-year to $2.48; the TTM figure through Mar 2026 stood at $11903.3 (up 100.19% YoY), while the FY2025 annual figure was -$0.23, down 60.01% from the prior year.
- Times Interest Earned for Q1 2026 stood at $2.48, up from -$0.0 in the prior quarter.
- The five-year high for Times Interest Earned was $2724.0 in Q4 2024, with the low at -$20.0 million in Q4 2023.
- The 5-year median for Times Interest Earned is -$320872.7 (2022), against an average of -$3.8 million.
- The sharpest annual moves came in 2023 and 2024: Times Interest Earned slumped 3023.24% in 2023, then soared 100.01% in 2024.
- Belite Bio's Times Interest Earned stood at -$641745.4 in 2022, then plunged by 3023.24% to -$20.0 million in 2023, then surged by 100.01% to $2724.0 in 2024, then sank by 100.0% to -$0.0 in 2025, then soared by 103443.81% to $2.48 in 2026.
- Business Quant data shows BLTE's Times Interest Earned at $2.48 in Q1 2026, -$0.0 in Q4 2025, and -$2.3 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | -21.24 |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 1.42 |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | -0.08 |
| 10 | Belite Bio | 6.25 Bn | 6.25 Bn | - | - |